BiotechTube
Cytoskeleton

Cytoskeleton

Denver, United States· Est.
cytoskeleton.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $500K

Overview

Cytoskeleton is a privately held, revenue-generating biotechnology tools and services company with over 30 years of operation. It has established a strong reputation for high-quality, reproducible research products, including its proprietary G-LISA and Signal-Seeker kits, and a trusted custom services division (CRO). The company serves a broad academic and industrial research market, evidenced by over 50,000 scholarly citations, and operates on a business model combining product sales with fee-for-service contracts. Its deep expertise in cytoskeletal and protein biochemistry provides a stable foundation for continued growth in the life sciences research tools sector.

Antibodies

Technology Platform

Proprietary assay platforms for protein biochemistry, including G-LISA® for GTPase activation and Signal-Seeker™ for post-translational modification analysis, combined with deep expertise in cytoskeletal protein purification and assay development.

Funding History

2
Total raised:$500K
Grant$300K
Grant$200K

Opportunities

Expansion of the post-translational modification (PTM) and live-cell imaging product lines addresses fast-growing research segments.
Scaling the custom CRO services division leverages the trend of research outsourcing and provides direct insight into emerging customer needs for new product development.
Strategic partnerships or expanded distribution could increase global market penetration.

Risk Factors

High dependence on cyclical academic and government research funding makes revenue sensitive to macroeconomic and policy shifts.
Intense competition from large, diversified life science suppliers and niche specialists requires continuous innovation.
Technological disruption from next-generation proteomic or analytical platforms could threaten established assay kits.

Competitive Landscape

Cytoskeleton competes in the fragmented life science research tools market against giants like Thermo Fisher Scientific and Merck Millipore, as well as numerous specialized boutiques. Its differentiation is built on deep expertise in cytoskeletal biology, high-quality, reproducible products, and exceptional, scientist-led technical support. It holds a strong niche position, particularly in GTPase and PTM analysis, where its proprietary kits are well-cited standards.

More companies in Biologics / Biosimilars →More companies in United States →